Global Lung Cancer Diagnostics Market Size & Outlook
Global lung cancer diagnostics market, 2021-2033 (US$M)
Related Markets
Global lung cancer diagnostics market highlights
- The global lung cancer diagnostics market generated a revenue of USD 12,371.2 million in 2024 and is expected to reach USD 23,309.5 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 7.3% by 2033.
- In terms of segment, non-small cell lung cancer (nsclc) accounted for a revenue of USD 8,954.7 million in 2024.
- Non-small cell lung cancer (NSCLC) is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 12,371.2 million |
| Market revenue in 2033 | USD 23,309.5 million |
| Growth rate | 7.3% (CAGR from 2025 to 2033) |
| Largest segment | Non-small cell lung cancer (nsclc) |
| Fastest growing segment | Non-small cell lung cancer (NSCLC) |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC) |
Other key industry trends
- In terms of revenue, the North America accounted for 40.2% of the global lung cancer diagnostics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 1,445.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lung Cancer Diagnostics Market Scope
Lung Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeoGenomics Inc | View profile | 2100 | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 | https://www.neogenomics.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global lung cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lung cancer diagnostics market will help companies and investors design strategic landscapes.
Non-small cell lung cancer (nsclc) was the largest segment with a revenue share of 72.38% in 2024. Horizon Databook has segmented the Global lung cancer diagnostics market based on small cell lung cancer (sclc), non-small cell lung cancer (nsclc) covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2021-2033)
- Small cell lung cancer (SCLC)
- Non-small cell lung cancer (NSCLC)
- Global Lung Cancer Diagnostics Test Type Outlook (Revenue, USD Million, 2021-2033)
- EGFR Mutation test
- CA test
- ALK test
- HER2 test
- Angiogenesis Inhibitors
- KRAS Mutation test
- Global Lung Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Laboratories
- Others
Reasons to subscribe to Global lung cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global lung cancer diagnostics market databook
-
Our clientele includes a mix of lung cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global lung cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global lung cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global lung cancer diagnostics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Lung cancer diagnostics market size, 2024 (US$M)
Global lung cancer diagnostics market share, by type, 2024 & 2033 (%, US$M)
Lung cancer diagnostics market: Opportunity assessment by country
Global lung cancer diagnostics market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
